Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. The estimated Net Worth of Bill Peck is at least $28.2 Million dollars as of 1 October 2019. Emily M. Leproust also recently made the following trade(s): Twist Bioscience (NASDAQ:TWST) last released its quarterly earnings data on Thursday, May 7th.
In addition, he makes $0 as Chief Technology Officer at Twist Bioscience. The company was founded in 2013 and is headquartered in San Francisco, California.Twist Bioscience's management team includes the following people: The 5G technology revolution has now arrived -- and with it comes a unique megatrend investing opportunity. On average, Emily trades about 15,556 units every 7 days since 2018.
Other family members and associates include Emily Leproust, Laetitia Leproust, Devlin Donnelly, Rebecca Blondin and Brennan Hartich. Finally, Legal & General Group Plc grew its position in Twist Bioscience by 14.7% in the first quarter.
All rights reserved. Company insiders that have sold Twist Bioscience company stock in the last year include Bill Peck, Emily M Leproust, James M Thorburn, Mark Daniels, Patrick John Finn, Patrick Weiss, Paula Green, and William Banyai. 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Twist Bioscience in the last year. E-MailELeproust@twistbioscience.com. Robert has made over 5 trades of the Twist Bioscience stock since 2019, according to the Form 4 filled with the SEC. Funding Events. Savvy investors should strongly consider putting these 5G stocks on their watchlist.Sr. It is illegal for insiders to make trades in their companies based on specific, non-public information. Following the sale, the chief executive officer now directly owns 738,055 shares in the company, valued at […] In addition, he … The shares were sold at an average price of $39.14, for a total value of $958,930.00. Taking into account various assets, Emily's net worth is greater than $1 - $4,999; and makes between $150 - 174,999 a year. High institutional ownership can be a signal of strong market trust in this company.Earnings for Twist Bioscience are expected to grow in the coming year, from ($3.00) to ($1.63) per share.The P/E ratio of Twist Bioscience is -12.68, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.The P/E ratio of Twist Bioscience is -12.68, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Twist Bioscience has a P/B Ratio of 12.10. Ms. Leproust owns over 20,000 units of Twist Bioscience stockTwist Bioscience stock The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. Ameritas Investment Partners Inc. increased its stake in Twist Bioscience by 22.4% in the 1st quarter. Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. Twist Bioscience Corp (NASDAQ:TWST) CEO Emily M. Leproust sold 24,500 shares of the firm’s stock in a transaction on Monday, June 1st. Read Full Summary. There are 14 older and 1 younger executives at Twist Bioscience. The oldest executive at Twist Bioscience Corp. is Twist Bioscience Corp. develops proprietary semiconductor-based synthetic DNA manufacturing process.
Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.Get daily stock ideas top-performing Wall Street analysts. ... Biopharma orders is worth noting, as Emily … Thank you, Jim. Following the transaction, the chief executive officer now directly owns 738,055 shares in the company, valued at […] The shares were sold at an average price of $39.14, for a total value of $958,930.00. Mr. Ragusa owns over 5,000 units of Twist Bioscience stock worth over $531,901 and over the last 7 years he sold TWST stock worth over $3,222,292. The estimated Net Worth of Emily M. Leproust is at least The largest trade she's ever made was selling 55,394 units of Twist Bioscience stock on 20 May 2020 worth over $2,198,588. As of 21 July 2020 she still owns at least As the Chairman of the Board, President a Chief Executive Officer of Twist Bioscience, the total compensation of Emily Leproust at Twist Bioscience is $8,126,160.